Back to top
more

Beauty Health (SKIN)

(Delayed Data from NSDQ)

$3.43 USD

3.43
938,747

+0.07 (2.08%)

Updated May 6, 2024 04:00 PM ET

After-Market: $3.42 -0.01 (-0.29%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for SKIN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for The Beauty Health Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 523 568 902 3 0
Receivables 55 78 51 0 0
Notes Receivable 0 0 0 0 0
Inventories 91 116 35 0 0
Other Current Assets 29 27 12 1 0
Total Current Assets 698 789 1,001 4 0
Net Property & Equipment 14 18 16 0 0
Investments & Advances 0 0 0 460 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1 1 0 0 0
Intangibles 188 171 180 0 0
Deposits & Other Assets 16 14 7 0 0
Total Assets 929 1,009 1,219 464 0
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 45 30 29 0 0
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 42 37 43 1 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 24 1 0 0 0
Total Current Liabilities 115 73 76 1 0
Mortgages 0 0 0 0 0
Deferred Taxes/Income 1 2 4 16 0
Convertible Debt 738 734 730 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 6 15 94 442 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 870 837 917 459 0
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 541 550 722 6 0
Retained Earnings -479 -374 -419 -1 0
Other Equity -3 -5 -1 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 59 171 302 5 0
Total Liabilities & Shareholder's Equity 929 1,009 1,219 464 0
Total Common Equity 59 171 302 5 0
Shares Outstanding 122.90 132.20 149.60 57.50 NA
Book Value Per Share 0.48 1.30 2.02 0.09 0.00

Fiscal Year End for The Beauty Health Company falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 523 559 550 532
Receivables NA 55 68 80 72
Notes Receivable NA 0 0 0 0
Inventories NA 91 75 107 122
Other Current Assets NA 29 36 31 22
Total Current Assets NA 698 738 768 749
Net Property & Equipment NA 14 16 18 18
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 1 1 1 1
Intangibles NA 188 189 191 196
Deposits & Other Assets NA 16 16 16 16
Total Assets NA 929 973 1,007 995
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 45 36 29 34
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 42 51 45 32
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 24 34 3 1
Total Current Liabilities NA 115 126 83 72
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 1 2 2 3
Convertible Debt NA 738 737 736 735
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 8 14 25
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 870 883 846 847
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 541 565 561 555
Retained Earnings NA -479 -469 -396 -404
Other Equity NA -3 -5 -4 -4
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 59 90 162 148
Total Liabilities & Shareholder's Equity NA 929 973 1,007 995
Total Common Equity 0 59 90 162 148
Shares Outstanding 123.40 122.90 132.50 132.80 132.60
Book Value Per Share 0.00 0.48 0.68 1.22 1.11